These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12603582)

  • 41. Modern management of hyperlipidemia.
    Grundy SM
    Compr Ther; 1984 Sep; 10(9):46-53. PubMed ID: 6091992
    [No Abstract]   [Full Text] [Related]  

  • 42. [Hyperlipoproteinemias in childhood].
    Widhalm K
    Wien Med Wochenschr; 1994; 144(12-13):320-3. PubMed ID: 8650937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnosis and therapy of familial hyper- -lipoproteinemia (familial hypercholesterolemia or familial hyperlipoproteinemia of type II)].
    Myant NB
    Recenti Prog Med; 1971 Nov; 51(5):420-37. PubMed ID: 5172396
    [No Abstract]   [Full Text] [Related]  

  • 44. Dietary therapy for different forms of hyperlipoproteinemia.
    Grundy SM
    Circulation; 1987 Sep; 76(3):523-8. PubMed ID: 3621518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atherosclerosis of the carotid arteries documented by duplex scan as a predictor of coronary artery disease in familial hyperlipidemias.
    Schuster HM; Kröner KK; Keller C; Spengel FA; Wolfram G; Zöllner N
    Klin Wochenschr; 1987 Jan; 65(1):34-9. PubMed ID: 3550265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Detection and treatment of of atherogenic hyperlipidemias].
    Dairou F
    J Mal Vasc; 1988; 13(4):365-7. PubMed ID: 3199038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipoprotein metabolism and the etiology of hyperlipidemia.
    Gotto AM
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():4-13. PubMed ID: 3134384
    [No Abstract]   [Full Text] [Related]  

  • 48. Rationale for early detection and treatment of hyperlipidemias.
    Stein EA
    Prog Clin Biol Res; 1985; 188():61-6. PubMed ID: 4059259
    [No Abstract]   [Full Text] [Related]  

  • 49. [Diagnosis and treatment of familial hypercholesterolemia in children and adolescents].
    Ose L; Tonstad S; Vesterhus P; Wefring KW
    Tidsskr Nor Laegeforen; 1995 Nov; 115(28):3499-503. PubMed ID: 7491603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand.
    N Z Med J; 1996 Jun; 109(1024):224-31. PubMed ID: 8769031
    [No Abstract]   [Full Text] [Related]  

  • 51. When and how to treat hyperlipidemia.
    Kuo PT
    Prim Care; 1985 Mar; 12(1):77-89. PubMed ID: 3873080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fifty years studying hiperlipidemias: the case of familial combined hyperlipidemia].
    Aguilar-Salinas C; Gómez-Díaz R; Tusié-Luna MT
    Invest Clin; 2010 Jun; 51(2):145-58. PubMed ID: 20928976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The application of molecular biology techniques to the diagnosis of hyperlipidaemia and other risk factors for cardiovascular disease. Committee on Molecular Biology Techniques in Clinical Chemistry of the International Federation of Clinical Chemistry (IFCC).
    Humphries SE
    J Int Fed Clin Chem; 1992 Dec; 4(5):208-18. PubMed ID: 10146701
    [No Abstract]   [Full Text] [Related]  

  • 55. Statin therapy and risk of diabetes in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas J; Liontou C; Chrysohoou C; Masoura C; Aznaouridis K; Pitsavos C; Stefanadis C
    Atherosclerosis; 2014 Nov; 237(1):140-5. PubMed ID: 25238223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of hyperlipidemia in the prevention of ischemic heart disease. A proposal for the unification of medical management. I and II].
    Adamska-Dyniewska H; Chojnowska-Jezierska J; Cybulska B; Dzieniszewski J; Hryniewiecki L; Idzior-Waluś B; Jabłońska-Kaszewska I; Jaszcz-Kanecka A; Kłosiewicz-Latoszek L; Kokot F
    Wiad Lek; 1992 May; 45(9-10):388-400. PubMed ID: 1441551
    [No Abstract]   [Full Text] [Related]  

  • 58. Primary hyperlipoproteinemia in infants.
    Fredrickson DS; Breslow JL
    Annu Rev Med; 1973; 24():315-24. PubMed ID: 4575862
    [No Abstract]   [Full Text] [Related]  

  • 59. The evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular disease.
    Thompson GR
    Atheroscler Suppl; 2013 Jan; 14(1):67-70. PubMed ID: 23357143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hyperlipidemia in elderly--pathophysiology and treatment].
    Kita T
    Nihon Ronen Igakkai Zasshi; 1996 Oct; 33(10):734-8. PubMed ID: 8958735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.